Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
FDA Updates Ozempic Label
The Food and Drug Administration updated the labeling for Ozempic acknowledging reports of blocked intestines for those that use the medication.
Load More